Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
3.317
-0.023 (-0.68%)
Oct 30, 2026, 10:16 AM EDT - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $10.83 million as of October 30, 2026. It is the 40,952nd most valuable company in the world and the 5,544th biggest in the United States. Its market cap has decreased by 17.28% in one year.
Market Cap
10.83M
Enterprise Value
1.40M
1-Year Change
-17.28%
Global Rank
Country Rank
#5,544 United States
Category
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $10.83M, a decrease of -83.59%. That is a compound annual growth rate of -41.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 10.83M | -56.04% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 10.89M |
| BioVie | 10.86M |
| Passage Bio | 10.78M |
| CytoMed Therapeutics | 10.62M |
| Purple Biotech | 10.49M |
| Phio Pharmaceuticals | 10.35M |
| GT Biopharma | 10.07M |
| Adial Pharmaceuticals | 9.74M |